Agios Pharma (AGIO) Tops Q3 EPS by 6c

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.64), $0.06 better than the analyst estimate of ($1.70). Revenue for the quarter came in at $7.34 million versus the consensus estimate of $7.64 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Agios Pharma (AGIO) PT Lowered to $31 at JPMorgan
• RH (RH) Tops Q1 EPS by 12c